Evidence map›Paper›PMID 9130711›Full record

ArticleThe EMBO journal1997

Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization.

Q Wu, Y Li, R Liu, A Agadir, M O Lee, Y Liu, X Zhang

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 160 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Targeting NR4A1 (TR3) in cancer cells and tumors.Expert opinion on therapeutic targets · 2011
    Review
  18. Retinoid pathway and cancer therapeutics.Advanced drug delivery reviews · 2010
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Q WuThe Burnham Institute, La Jolla Cancer Research Center, CA 92037, USA.
Y Li
R Liu
A Agadir
M O Lee
Y Liu
X Zhang
Sanford Burnham Prebys Medical Discovery Institute · US

Funding

RETINOIC ACID RESPONSE IN HUMAN LUNG CANCERR01CA060988 · NCI · BURNHAM INSTITUTE FOR MEDICAL RESEARCH · PI ZHANG, XIAO-KUN · 1993 to 2002
$940k
NCI NIH HHS CA51933NCI NIH HHS CA60988
6 · The paper itself

Abstract

The diverse function of retinoic acid (RA) is mediated by its nuclear receptors, the retinoic acid receptors (RARs) and retinoid X receptors (RXRs). However, the RA response is often lost in cancer cells that express the receptors. Previously, it was demonstrated that the RA response is regulated by the COUP-TF orphan receptors. Here, we present evidence that nur77, another orphan receptor whose expression is highly induced by phorbol esters and growth factors, is involved in modulation of the RA response. Expression of nur77 enhances ligand-independent transactivation of RA response elements (RAREs) and desensitizes their RA responsiveness. Conversely, expression of COUP-TF sensitizes RA responsiveness of RAREs by repressing their basal transactivation activity. Unlike the effect of COUP-TFs, the function of nur77 does not require direct binding of nur77 to the RAREs, but is through interaction between nur77 and COUP-TFs. The interaction occurs in solution and results in inhibition of COUP-TF RARE binding and transcriptional activity. Unlike other nuclear receptors, a large portion of the carboxy-terminal end of nur77 is not required for its interaction with COUP-TF. In human lung cancer cell lines, COUP-TF is highly expressed in RA-sensitive cell lines while nur77 expression is associated with RA resistance. Stable expression of COUP-TF in nur77-positive, RA-resistant lung cancer cells enhances the inducibility of RARbeta gene expression and growth inhibition by RA. These observations demonstrate that a dynamic equilibrium between orphan receptors nur77 and COUP-TF, through their heterodimerization that regulates COUP-TF RARE binding, is critical for RA responsiveness of human lung cancer cells.

Indexed as

AnimalsAntineoplastic AgentsBinding SitesCell LineChlorocebus aethiopsCloning, MolecularCOUP Transcription Factor IDimerizationDNA-Binding ProteinsGene ExpressionGlutathione TransferaseHumansLung NeoplasmsNuclear Receptor Subfamily 4, Group A, Member 1Receptors, Cytoplasmic and NuclearReceptors, GlucocorticoidAntineoplastic AgentsCOUP Transcription Factor IDNA-Binding ProteinsGlutathione TransferaseNR2F1 protein, humanNR4A1 protein, humanNuclear Receptor Subfamily 4, Group A, Member 1Receptors, Cytoplasmic and NuclearReceptors, GlucocorticoidReceptors, SteroidRecombinant Fusion ProteinsTranscription FactorsTretinoin

Identifiers

PMID9130711
PMCPMC1169770
OpenAlexW2119908949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.